The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Docking Screens for Novel Ligands Conferring New Biology: Miniperspective
Open accessAbstract
It is now plausible to dock libraries of 10 million molecules against targets over several days or weeks. When the molecules screened are commercially available, they may be rapidly tested to find new leads. Although docking retains important liabilities (it cannot calculate affinities accurately nor even reliably rank order high-scoring molecules), it can often can distinguish likely from unlikely ligands, often with hit rates above 10%. Here we summarize the improvements in libraries, target quality, and methods that have supported these advances, and the open access resources that make docking accessible. Recent docking screens for new ligands are sketched, as are the binding, crystallographic, and in vivo assays that support them. Like any technique, controls are crucial, and key experimental ones are reviewed. With such controls, docking campaigns can find ligands with new chemotypes, often revealing the new biology that may be docking's greatest impact over the next few years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Self-citationBaell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Self-citationMolecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Protein Structure Modeling with MODELLER
Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., & Sali, A. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-60327-058-8_8 · Cited by 1,773
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,172
ModBase, a database of annotated comparative protein structure models, and associated resources
Pieper, U., Webb, B. M., Barkan, D. T., Schneidman-Duhovny, D., Schlessinger, A., Braberg, H., Yang, Z., Meng, E. C., Pettersen, E. F., Huang, C. C., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1091 · Cited by 1,071
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
Self-citationThe promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
Self-citationIs There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”
Mobley, D. L., & Dill, K. A. (2009) · Structure · doi:10.1016/j.str.2009.02.010 · Cited by 584
Protein Structure Modeling with MODELLER
Webb, B., & Sali, A. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0366-5_1 · Cited by 549
Sun, L., Tran, N., Tang, F., App, H., Hirth, P., McMahon, G., & Tang, C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980123i · Cited by 489
Comprehensive medicinal chemistry II
Taylor, J. B. (2007) · Cited by 468
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
Zhu, K., Borrelli, K. W., Greenwood, J. R., Day, T., Abel, R., Farid, R. S., & Harder, E. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500118s · Cited by 462
Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings, W. C., Connolly, D. T., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010548w · Cited by 462
Self-citationApparent activity in high-throughput screening: origins of compound-dependent assay interference
Thorne, N., Auld, D. S., & Inglese, J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.020 · Cited by 430
A detergent-based assay for the detection of promiscuous inhibitors
Feng, B. Y., & Shoichet, B. K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.77 · Cited by 429
Self-citationStructural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., et al. (2013) · Nature · doi:10.1038/nature12595 · Cited by 411
Feng, J., Zhang, Z., Wallace, M. B., Stafford, J. A., Kaldor, S. W., Kassel, D. B., Navre, M., Shi, L., Skene, R. J., Asakawa, T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070104l · Cited by 405
Conformer Generation with OMEGA: Learning from the Data Set and the Analysis of Failures
Hawkins, P. C. D., & Nicholls, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300314k · Cited by 403
Modeling water molecules in protein-ligand docking using GOLD.
Verdonk, M. L., Chessari, G., Cole, J. C., Hartshorn, M. J., Murray, C. W., Nissink, J. W. M., Taylor, R. D., & Taylor, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050543p · Cited by 393
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Fluorescence polarization assays in small molecule screening
Lea, W. A., & Simeonov, A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.537322 · Cited by 379
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 374
Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria
Jorgensen, W. L., & Thomas, L. L. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct800011m · Cited by 369
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
Foloppe, N., Fisher, L. M., Howes, R., Potter, A., Robertson, A. G. S., & Surgenor, A. E. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.021 · Cited by 363
Wacker, D., Fenalti, G., Brown, M. A., Katritch, V., Abagyan, R., Cherezov, V., & Stevens, R. C. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105108q · Cited by 358
A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., & Austin, C. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061317y · Cited by 358
Self-citationFragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
High-throughput assays for promiscuous inhibitors
Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., & Shoichet, B. K. (2005) · Nature Chemical Biology · doi:10.1038/nchembio718 · Cited by 336
Self-citationNguyen, C. N., Kurtzman Young, T., & Gilson, M. K. (2012) · The Journal of Chemical Physics · doi:10.1063/1.4733951 · Cited by 324
ModBase, a database of annotated comparative protein structure models and associated resources
Pieper, U., Webb, B. M., Dong, G. Q., Schneidman-Duhovny, D., Fan, H., Kim, S. J., Khuri, N., Spill, Y. G., Weinkam, P., Hammel, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1144 · Cited by 322
Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening
Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010016f · Cited by 315
Predicting Absolute Ligand Binding Free Energies to a Simple Model Site
Mobley, D. L., Graves, A. P., Chodera, J. D., McReynolds, A. C., Shoichet, B. K., & Dill, K. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.002 · Cited by 310
Self-citationLigand discovery from a dopamine D3 receptor homology model and crystal structure
Carlsson, J., Coleman, R. G., Setola, V., Irwin, J. J., Fan, H., Schlessinger, A., Sali, A., Roth, B. L., & Shoichet, B. K. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.662 · Cited by 308
Self-citationInterpreting steep dose-response curves in early inhibitor discovery.
Shoichet, B. K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061103g · Cited by 304
Self-citationStructure-based drug screening for G-protein-coupled receptors
Shoichet, B. K., & Kobilka, B. K. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.007 · Cited by 294
Self-citationA Force Field with Discrete Displaceable Waters and Desolvation Entropy for Hydrated Ligand Docking
Forli, S., & Olson, A. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2005145 · Cited by 290
Structure-based discovery of β 2 -adrenergic receptor ligands
Kolb, P., Rosenbaum, D. M., Irwin, J. J., Fung, J. J., Kobilka, B. K., & Shoichet, B. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812657106 · Cited by 288
Self-citationClassification of Water Molecules in Protein Binding Sites
Barillari, C., Taylor, J., Viner, R., & Essex, J. W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja066980q · Cited by 285
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
Huang, X.-P., Karpiak, J., Kroeze, W. K., Zhu, H., Chen, X., Moy, S. S., Saddoris, K. A., Nikolova, V. D., Farrell, M. S., Wang, S., et al. (2015) · Nature · doi:10.1038/nature15699 · Cited by 284
Self-citationScreening in a spirit haunted world
Shoichet, B. K. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.014 · Cited by 276
Self-citationCovalent docking of large libraries for the discovery of chemical probes
London, N., Miller, R. M., Krishnan, S., Uchida, K., Irwin, J. J., Eidam, O., Gibold, L., Cimermančič, P., Bonnet, R., Shoichet, B. K., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1666 · Cited by 274
Self-citationTirado-Rives, J., & Jorgensen, W. L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060763i · Cited by 270
Fluorescence Spectroscopic Profiling of Compound Libraries
Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., Shinn, P., Smith, J., Austin, C. P., Auld, D. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701301m · Cited by 262
Markov State Models Provide Insights into Dynamic Modulation of Protein Function
Shukla, D., Hernández, C. X., Weber, J. K., & Pande, V. S. (2015) · Accounts of Chemical Research · doi:10.1021/ar5002999 · Cited by 258
Structure-based activity prediction for an enzyme of unknown function
Hermann, J. C., Marti-Arbona, R., Fedorov, A. A., Fedorov, E., Almo, S. C., Shoichet, B. K., & Raushel, F. M. (2007) · Nature · doi:10.1038/nature05981 · Cited by 256
Self-citationMolecular docking and ligand specificity in fragment-based inhibitor discovery
Chen, Y., & Shoichet, B. K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.155 · Cited by 252
Self-citationComplementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors
Ferreira, R. S., Simeonov, A., Jadhav, A., Eidam, O., Mott, B. T., Keiser, M. J., McKerrow, J. H., Maloney, D. J., Irwin, J. J., & Shoichet, B. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100488w · Cited by 247
Self-citationCovalent docking using autodock: two-point attractor and flexible side chain methods.
Bianco, G., Forli, S., Goodsell, D. S., & Olson, A. J. (2016) · Protein Science · doi:10.1002/pro.2733 · Cited by 246
Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor Antagonists
Katritch, V., Jaakola, V.-P., Lane, J. R., Lin, J., IJzerman, A. P., Yeager, M., Kufareva, I., Stevens, R. C., & Abagyan, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901647p · Cited by 245
Jadhav, A., Ferreira, R. S., Klumpp, C., Mott, B. T., Austin, C. P., Inglese, J., Thomas, C. J., Maloney, D. J., Shoichet, B. K., & Simeonov, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901070c · Cited by 238
Self-citationA model binding site for testing scoring functions in molecular docking.
Wei, B. Q., Baase, W. A., Weaver, L. H., Matthews, B. W., & Shoichet, B. K. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00777-5 · Cited by 237
Self-citationKinase Inhibitors: Not Just for Kinases Anymore
McGovern, S. L., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020427b · Cited by 230
Self-citationStructure-Based Discovery of A 2A Adenosine Receptor Ligands
Carlsson, J., Yoo, L., Gao, Z.-G., Irwin, J. J., Shoichet, B. K., & Jacobson, K. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100240h · Cited by 227
Self-citationStoichiometry and Physical Chemistry of Promiscuous Aggregate-Based Inhibitors
Coan, K. E. D., & Shoichet, B. K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802977h · Cited by 225
Self-citationLippert, R. A., Predescu, C., Ierardi, D. J., Mackenzie, K. M., Eastwood, M. P., Dror, R. O., & Shaw, D. E. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4825247 · Cited by 209
Aliskiren: the first renin inhibitor for clinical treatment
Jensen, C., Herold, P., & Brunner, H. R. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2550 · Cited by 205
Sorna, V., Theisen, E. R., Stephens, B., Warner, S. L., Bearss, D. J., Vankayalapati, H., & Sharma, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400870h · Cited by 204
de Graaf, C., Kooistra, A. J., Vischer, H. F., Katritch, V., Kuijer, M., Shiroishi, M., Iwata, S., Shimamura, T., Stevens, R. C., de Esch, I. J. P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2011589 · Cited by 204
Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening
Ostrov, D. A., Hernández Prada, J. A., Corsino, P. E., Finton, K. A., Le, N., & Rowe, T. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00392-07 · Cited by 204
Scholz, C., Knorr, S., Hamacher, K., & Schmidt, B. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500681r · Cited by 203
Honma, T., Hayashi, K., Aoyama, T., Hashimoto, N., Machida, T., Fukasawa, K., Iwama, T., Ikeura, C., Ikuta, M., Suzuki-Takahashi, I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103256 · Cited by 203
Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands
Richter, L., de Graaf, C., Sieghart, W., Varagic, Z., Mörzinger, M., de Esch, I. J. P., Ecker, G. F., & Ernst, M. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.917 · Cited by 197
Rescoring Docking Hit Lists for Model Cavity Sites: Predictions and Experimental Testing
Graves, A. P., Shivakumar, D. M., Boyce, S. E., Jacobson, M. P., Case, D. A., & Shoichet, B. K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.049 · Cited by 197
Self-citationStructure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor
Huentelman, M. J., Zubcevic, J., Hernández Prada, J. A., Xiao, X., Dimitrov, D. S., Raizada, M. K., & Ostrov, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000146120.29648.36 · Cited by 188
Prediction of the Water Content in Protein Binding Sites
Michel, J., Tirado-Rives, J., & Jorgensen, W. L. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9047456 · Cited by 180
Babaoglu, K., Simeonov, A., Irwin, J. J., Nelson, M. E., Feng, B., Thomas, C. J., Cancian, L., Costi, M. P., Maltby, D. A., Jadhav, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701500e · Cited by 178
Self-citationMessaoudi, A., Belguith, H., & Hamida, J. B. (2013) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-10-22 · Cited by 178
Inhomogeneous Fluid Approach to Solvation Thermodynamics. 2. Applications to Simple Fluids
Lazaridis, T. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp972358w · Cited by 174
Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture
Owen, S. C., Doak, A. K., Wassam, P., Shoichet, M. S., & Shoichet, B. K. (2012) · ACS Chemical Biology · doi:10.1021/cb300189b · Cited by 171
Self-citationStructure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands
Warshaviak, D. T., Golan, G., Borrelli, K. W., Zhu, K., & Kalid, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500175r · Cited by 169
Small-Molecule Activators of a Proenzyme
Wolan, D. W., Zorn, J. A., Gray, D. C., & Wells, J. A. (2009) · Science · doi:10.1126/science.1177585 · Cited by 169
Evers, A., & Klebe, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311487 · Cited by 161
Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
Kumalo, H., Bhakat, S., & Soliman, M. (2015) · Molecules · doi:10.3390/molecules20021984 · Cited by 158
Repasky, M. P., Murphy, R. B., Banks, J. L., Greenwood, J. R., Tubert-Brohman, I., Bhat, S., & Friesner, R. A. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9575-9 · Cited by 158
Receptor-based virtual screening protocol for drug discovery
Cerqueira, N. M. F. S. A., Gesto, D., Oliveira, E. F., Santos‐Martins, D., Brás, N. F., Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.05.011 · Cited by 151
Discovery and characterization of small molecules that target the GTPase Ral
Yan, C., Liu, D., Li, L., Wempe, M. F., Guin, S., Khanna, M., Meier, J., Hoffman, B., Owens, C., Wysoczynski, C. L., et al. (2014) · Nature · doi:10.1038/nature13713 · Cited by 150
Fischer, M., Coleman, R. G., Fraser, J. S., & Shoichet, B. K. (2014) · Nature Chemistry · doi:10.1038/nchem.1954 · Cited by 149
Self-citationDiscovery of new enzymes and metabolic pathways by using structure and genome context
Zhao, S., Kumar, R., Sakai, A., Vetting, M. W., Wood, B. M., Brown, S. D., Bonanno, J. B., Hillerich, B., Seidel, R. D., Babbitt, P. C., et al. (2013) · Nature · doi:10.1038/nature12576 · Cited by 144
Ouyang, X., Zhou, S., Su, C. T. T., Ge, Z., Li, R., & Kwoh, C. K. (2013) · Journal of Computational Chemistry · doi:10.1002/jcc.23136 · Cited by 134
Thorne, N., Shen, M., Lea, W., Simeonov, A. M., Lovell, S., Auld, D. S., & Inglese, J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.015 · Cited by 133
Exploiting Ordered Waters in Molecular Docking
Huang, N., & Shoichet, B. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006239 · Cited by 133
Self-citationSpyrakis, F., & Cavasotto, C. N. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.08.002 · Cited by 133
COMPOUNDS DESIGNED TO FIT A SITE OF KNOWN STRUCTURE IN HUMAN HAEMOGLOBIN
Beddell, C. R., Goodford, P. J., Norrington, F. E. A., Wilkinson, S., & Wootton, R. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07468.x · Cited by 132
Abel, R., Salam, N. K., Shelley, J. C., Farid, R., Friesner, R. A., & Sherman, W. (2011) · ChemMedChem · doi:10.1002/cmdc.201000533 · Cited by 127
Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase
Pierce, A. C., Jacobs, M. D., & Moody, C. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701248t · Cited by 121
Structure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase
Powers, R. A., Morandi, F., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00799-2 · Cited by 121
Self-citationVirtual screening in lead discovery and optimization.
Jain, A. N. (2004) · PubMed · Cited by 116
Varney, M. D., Marzoni, G. P., Palmer, C. L., Deal, J. G., Webber, S., Welsh, K. M., Bacquet, R. J., Bartlett, C. A., & Morse, C. A. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00082a006 · Cited by 116
Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors
Sassano, M. F., Doak, A. K., Roth, B. L., & Shoichet, B. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301749y · Cited by 110
Self-citationCho, Y., Ioerger, T. R., & Sacchettini, J. C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800328v · Cited by 109
Mpamhanga, C. P., Spinks, D., Tulloch, L. B., Shanks, E. J., Robinson, D. A., Collie, I. T., Fairlamb, A. H., Wyatt, P. G., Frearson, J. A., Hunter, W. N., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900414x · Cited by 105
Docking for fragment inhibitors of AmpC β-lactamase
Teotico, D. G., Babaoglu, K., Rocklin, G. J., Ferreira, R. S., Giannetti, A. M., & Shoichet, B. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813029106 · Cited by 102
Self-citationpKa based protonation states and microspecies for protein–ligand docking
ten Brink, T., & Exner, T. E. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9385-x · Cited by 99
Evers, A., & Klebe, G. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352776 · Cited by 99
Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors
Fazi, R., Tintori, C., Brai, A., Botta, L., Selvaraj, M., Garbelli, A., Maga, G., & Botta, M. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00419 · Cited by 98
Wiggers, H. J., da Rocha, J. R., Fernandes, W. B., Sesti‐Costa, R., Carneiro, Z. A., Cheleski, J., da Silva, A. B. F., Juliano, L., Cezari, M. H. S., Silva, J. S., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002370 · Cited by 93
Nogara, P. A., Saraiva, R. D. A., Caeran Bueno, D., Lissner, L. J., Lenz Dalla Corte, C., Braga, M. M., Rosemberg, D. B., & Rocha, J. B. T. (2015) · BioMed Research International · doi:10.1155/2015/870389 · Cited by 89
Charting a Path to Success in Virtual Screening
Forli, S. (2015) · Molecules · doi:10.3390/molecules201018732 · Cited by 89
Paiva, A. M., Vanderwall, D. E., Blanchard, J. S., Kozarich, J. W., Williamson, J. M., & Kelly, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00262-4 · Cited by 88
Soelaiman, S., Wei, B. Q., Bergson, P., Lee, Y., Shen, Y., Mrksich, M., Shoichet, B. K., & Tang, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301232200 · Cited by 86
Self-citationDiscovery of Small Molecule CD40–TRAF6 Inhibitors
Zarzycka, B. A., Seijkens, T. T. P., Nabuurs, S. B., Ritschel, T., Grommes, J., Soehnlein, O., Schrijver, R., van Tiel, C. M., Hackeng, T. M., Weber, C., et al. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500631e · Cited by 83
Kalid, O., Warshaviak, D. T., Shechter, S., Sherman, W., & Shacham, S. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9611-9 · Cited by 81
Adeniyi, A. A., & Ajibade, P. A. (2013) · Molecules · doi:10.3390/molecules18043760 · Cited by 81
The Recognition of Identical Ligands by Unrelated Proteins
Barelier, S., Sterling, T., O’Meara, M. J., & Shoichet, B. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00683 · Cited by 81
Self-citationGrädler, U., Gerber, H., Goodenough-Lashua, D. M., Garcia, G. A., Ficner, R., Reuter, K., Stubbs, M. T., & Klebe, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4256 · Cited by 77
Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II
Grüneberg, S., Wendt, B., & Klebe, G. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010119)40:2<389::aid-anie389>3.0.co;2-# · Cited by 76
Molecular Docking Screening Using Agonist-Bound GPCR Structures: Probing the A2A Adenosine Receptor
Rodriguez, D. J., Gao, Z.-G., Moss, S. M., Jacobson, K. A., & Carlsson, J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500639g · Cited by 74
Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
Zhao, H., Gartenmann, L., Dong, J., Spiliotopoulos, D., & Caflisch, A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.017 · Cited by 73
Increasing Chemical Space Coverage by Combining Empirical and Computational Fragment Screens
Barelier, S., Eidam, O., Fish, I., Hollander, J. G., Figaroa, F., Nachane, R., Irwin, J. J., Shoichet, B. K., & Siegal, G. (2014) · ACS Chemical Biology · doi:10.1021/cb5001636 · Cited by 73
Self-citationde Graaf, C., Rein, C., Piwnica, D., Giordanetto, F., & Rognan, D. (2011) · ChemMedChem · doi:10.1002/cmdc.201100317 · Cited by 72
Mizutani, M., & Itai, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030605g · Cited by 71
Colas, C., Grewer, C. T., Otte, N. J., Gameiro, A. M., Albers, T., Singh, K., Shere, H., Bonomi, M., Holst, J., & Schlessinger, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004477 · Cited by 69
Ouizougun-Oubari, M., Pereira, N., Tarus, B., Galloux, M., Lassoued, S., Fix, J., Tortorici, M. A., Hoos, S., Baron, B., England, P., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01612-15 · Cited by 68
Gasser, A., Brogi, S., Urayama, K., Nishi, T., Kurose, H., Tafi, A., Ribeiro, N., Désaubry, L., & Nebigil, C. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121027 · Cited by 68
Probing Molecular Docking in a Charged Model Binding Site
Brenk, R., Vetter, S. W., Boyce, S. E., Goodin, D. B., & Shoichet, B. K. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.034 · Cited by 66
Self-citationTondi, D., Morandi, F., Bonnet, R., Costi, M. P., & Shoichet, B. K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042984o · Cited by 64
Self-citationFreymann, D. M., Wenck, M. A., Engel, J. C., Feng, J., Focia, P. J., Eakin, A. E., & Craig, S. P. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00045-4 · Cited by 63
Lee, H., Mittal, A., Patel, K., Gatuz, J. L., Truong, L., Torres, J., Mulhearn, D. C., & Johnson, M. E. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.041 · Cited by 62
Blind Prediction of Charged Ligand Binding Affinities in a Model Binding Site
Rocklin, G. J., Boyce, S. E., Fischer, M. M., Fish, I., Mobley, D. L., Shoichet, B. K., & Dill, K. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.030 · Cited by 60
Self-citationMeng, F., Cheng, S.-F., Ding, H., Liu, S., Liu, Y., Zhu, K., Chen, S., Lu, J., Xie, Y., Li, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01154 · Cited by 60
Borriello, L., Montès, M., Lepelletier, Y., Leforban, B., Liu, W., Demange, L., Delhomme, B., Pavoni, S., Jarray, R., Boucher, J. L., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.004 · Cited by 59
Chang, C., Jeyachandran, S., Hu, N., Liu, C.-L., Lin, S.-Y., Wang, Y., Chang, Y.-M., & Hou, M. (2015) · Molecular BioSystems · doi:10.1039/c5mb00582e · Cited by 58
Kalyanaraman, C., Imker, H. J., Fedorov, A. A., Fedorov, E. V., Glasner, M. E., Babbitt, P. C., Almo, S. C., Gerlt, J. A., & Jacobson, M. P. (2008) · Structure · doi:10.1016/j.str.2008.08.015 · Cited by 55
In silico discovery of novel Retinoic Acid Receptor agonist structures
Schapira, M., Raaka, B. M., Samuels, H. H., & Abagyan, R. A. (2001) · BMC Structural Biology · doi:10.1186/1472-6807-1-1 · Cited by 54
Zhong, Z., Liu, L., Dong, Z., Lu, L., Wang, M., Leung, C., Ma, D., & Wang, Y. (2015) · Chemical Communications · doi:10.1039/c5cc02728d · Cited by 52
Leva, F. S. D., Zizza, P., Cingolani, C., D’Angelo, C., Pagano, B., Amato, J., Salvati, E., Sissi, C., Pinato, O., Marinelli, L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401185b · Cited by 52
Ragno, R., Mai, A., Massa, S., Cerbara, I., Valente, S., Bottoni, P., Scatena, R., Jesacher, F., Loidl, P., & Brosch, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031036f · Cited by 51
Lavecchia, A., Giovanni, C. D., Pesapane, A., Montuori, N., Ragno, P., Martucci, N. M., Masullo, M., Vendittis, E. D., & Novellino, E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201624h · Cited by 50
Zhong, H., Liu, L., Chong, C., Lu, L., Wang, M., Chan, D. S., Chan, P. W. H., Lee, S. M., Ma, D., & Leung, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092905 · Cited by 49
Lee, H., Bao, J., Miller, A., Zhang, C., Wu, J., Baday, Y. C., Guibao, C. D., Li, L., Wu, D., & Zheng, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.673202 · Cited by 49
Pottel, J., Therrien, E., Gleason, J. L., & Moitessier, N. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400550m · Cited by 48
Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques
Chen, Y., Fang, L., Peng, S., Liao, H., Lehmann, J., & Zhang, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.046 · Cited by 47
Kasam, V., Salzemann, J., Botha, M., Dacosta, A., Degliesposti, G., Isea, R., Kim, D., Maaß, A., Kenyon, C. P., Rastelli, G., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-88 · Cited by 47
Bavan, S., Sherman, B., Luetje, C. W., & Abaffy, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092064 · Cited by 44
Opportunities for structure-based design of protease-directed drugs
Mittl, P. R. E., & Grütter, M. G. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.10.014 · Cited by 43
Successful in Silico Discovery of Novel Nonsteroidal Ligands for Human Sex Hormone Binding Globulin
Cherkasov, A. R., Shi, Z., Fallahi, M., & Hammond, G. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049087f · Cited by 42
Zhou, Y., Ma, J., Lin, X., Huang, X., Wu, K., & Huang, N. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01631 · Cited by 42
Discovery of novel SecA inhibitors of Candidatus Liberibacter asiaticus by structure based design
Akula, N., Zheng, H., Han, F. Q., & Wang, N. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.086 · Cited by 41
Zhang, S., Tan, J., Lai, Z., Li, Y., Pang, J., Xiao, J., Huang, Z., Zhang, Y., Ji, H., & Lai, Y. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5002058 · Cited by 40
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity Using Multi-Target Docking
Schmidt, D., Bernat, V., Brox, R., Tschammer, N., & Kolb, P. (2014) · ACS Chemical Biology · doi:10.1021/cb500577j · Cited by 40
A Strategy for the Chemotherapy of Infectious Disease
Cohen, S. S. (1977) · Science · doi:10.1126/science.195340 · Cited by 39
Afzal, O., Kumar, S., Kumar, R., Firoz, A., Jaggi, M., & Bawa, S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.029 · Cited by 38
Pang, Y., Xu, K., Kollmeyer, T. M., Perola, E., McGrath, W. J., Green, D. T., & Mangel, W. F. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02672-2 · Cited by 37
A Virtual Screen Discovers Novel, Fragment-Sized Inhibitors ofMycobacterium tuberculosisInhA
Perryman, A. L., Yu, W., Wang, X., Ekins, S., Forli, S., Li, S., Freundlich, J. S., Tonge, P. J., & Olson, A. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500672v · Cited by 36
Fan, H., Hitchcock, D., Seidel, R., Hillerich, B., Lin, H., Almo, S., Sali, A., Shoichet, B., & Raushel, F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309680b · Cited by 36
Self-citationProspective Virtual Screening in a Sparse Data Scenario: Design of Small‐Molecule TLR2 Antagonists
Murgueitio, M. S., Henneke, P., Glossmann, H. H., Santos‐Sierra, S., & Wolber, G. (2014) · ChemMedChem · doi:10.1002/cmdc.201300445 · Cited by 36
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking
Rettenmaier, T. J., Fan, H., Karpiak, J. D., Doak, A. K., Šali, A., Shoichet, B. K., & Wells, J. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01216 · Cited by 35
Self-citationDhanjal, J. K., Sreenidhi, A. K., Bafna, K., Katiyar, S. P., Goyal, S., Grover, A., & Sundar, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134691 · Cited by 34
Min, J. S., Lin, D., Zhang, Q., Zhang, J., & Yu, Z. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.051 · Cited by 34
Covalent Docking Predicts Substrates for Haloalkanoate Dehalogenase Superfamily Phosphatases
London, N., Farelli, J. D., Brown, S. D., Liu, C., Huang, H., Korczynska, M., Al-Obaidi, N. F., Babbitt, P. C., Almo, S. C., Allen, K. N., et al. (2014) · Biochemistry · doi:10.1021/bi501140k · Cited by 33
Self-citationConsensus models for CDK5 inhibitors in silico and their application to inhibitor discovery
Fang, J., Yang, R., Gao, L., Yang, S., Pang, X., Li, C., He, Y., Liu, A., & Du, G. (2014) · Molecular Diversity · doi:10.1007/s11030-014-9561-3 · Cited by 32
CovalentDock Cloud: a web server for automated covalent docking
Ouyang, X., Zhou, S., Ge, Z., Li, R., & Kwoh, C. K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt406 · Cited by 32
Hou, X., Li, K., Yu, X., Sun, J., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00344 · Cited by 30
Fakhouri, L. I., El‐Elimat, T., Hurst, D. P., Reggio, P. H., Pearce, C. J., Oberlies, N. H., & Croatt, M. P. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.09.037 · Cited by 28
Kobayashi, M., Kinjo, T., Koseki, Y., Bourne, C. R., Barrow, W. W., & Aoki, S. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400686d · Cited by 28
Water PMF for predicting the properties of water molecules in protein binding site
Zheng, M., Li, Y., Xiong, B., Jiang, H., & Shen, J. (2012) · Journal of Computational Chemistry · doi:10.1002/jcc.23170 · Cited by 28
Molecular dynamics to enhance structure-based virtual screening on cathepsin B
Ogrizek, M., Turk, S., Lešnik, S., Sosič, I., Hodošček, M., Mirković, B., Kos, J., Janežič, D., Gobec, S., & Konc, J. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9847-2 · Cited by 28
Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation
Allen, W. J., Yi, H., Gochin, M., Jacobs, A., & Rizzo, R. C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.067 · Cited by 27
Structure-based identification of novel PPAR gamma ligands
da Silva, F. M. C., Santos, J. C., Campos, J. C. L. D. O., Mafud, A. C., Polikarpov, I., Figueira, A. C. M., & Nascimento, A. S. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.010 · Cited by 27
Mahasenan, K. V., & Li, C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300040c · Cited by 26
Parmenopoulou, V., Kantsadi, A. L., Tsirkone, V. G., Chatzileontiadou, D. S. M., Manta, S., Zographos, S. E., Molfeta, C., Archontis, G., Agius, L., Hayes, J. M., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.058 · Cited by 26
Tanwar, O., Tanwar, L., Shaquiquzzaman, M., Alam, M. M., & Akhter, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.076 · Cited by 26
Ruggeri, C., Drinkwater, N., Sivaraman, K. K., Bamert, R. S., McGowan, S., & Paiardini, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138957 · Cited by 26
Proteome-scale docking: myth and reality
Rognan, D. (2013) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2013.01.003 · Cited by 25
Wang, D., Wang, F., Tan, Y., Dong, L., Chen, L., Zhu, W., & Wang, H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.043 · Cited by 25
Prediction of Substrates for Glutathione Transferases by Covalent Docking
Dong, G. Q., Calhoun, S., Fan, H., Kalyanaraman, C., Branch, M. C., Mashiyama, S. T., London, N., Jacobson, M. P., Babbitt, P. C., Shoichet, B. K., et al. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5001554 · Cited by 25
Self-citationDocking studies on the interaction of flavonoids with fat mass and obesity associated protein
Mohammed, A., Al-Numair, K. S., & Balakrishnan, A. (2015) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/28/5/2015/3076/1647-1653 · Cited by 25
Modeling of Proteins and Their Assemblies with the Integrative Modeling Platform
Webb, B., Lasker, K., Schneidman‐Duhovny, D., Tjioe, E., Phillips, J. L., Kim, S. J., Velázquez-Muriel, J. A., Russel, D., & Šali, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-276-2_19 · Cited by 25
Mathew, S., Fatima, K., Fatmi, M. Q., Archunan, G., Ilyas, M., Begum, N., Azhar, E. I., Damanhouri, G. A., & Qadri, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126510 · Cited by 24
Roles for Ordered and Bulk Solvent in Ligand Recognition and Docking in Two Related Cavities
Barelier, S., Boyce, S. E., Fish, I., Fischer, M. M., Goodin, D. B., & Shoichet, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069153 · Cited by 24
Self-citationCovalent docking of selected boron-based serine beta-lactamase inhibitors
Sgrignani, J., Novati, B., Colombo, G., & Grazioso, G. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9834-7 · Cited by 24
Sun, R., Li, X., Li, Y., Zhang, X., Li, X., Li, X., Shi, Z., & Bao, J. (2015) · Journal of Molecular Modeling · doi:10.1007/s00894-015-2675-4 · Cited by 24
Protocol for Rational Design of Covalently Interacting Inhibitors
Schmidt, T. C., Welker, A., Rieger, M., Sahu, P. K., Sotriffer, C., Schirmeister, T., & Engels, B. (2014) · ChemPhysChem · doi:10.1002/cphc.201402542 · Cited by 24
Lee, T. V., Johnson, R. D., Arcus, V. L., & Lott, J. S. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24922 · Cited by 24
Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening
Li, S., Sun, X., Zhao, H., Tang, Y., & Lan, M. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.092 · Cited by 23
Li, Y., Kim, D. J., Ma, W., Lubet, R. A., Bode, A. M., & Dong, Z. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200257b · Cited by 23
Nolan, K. A., Dunstan, M. S., Caraher, M. C., Scott, K. A., Leys, D., & Stratford, I. J. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0543 · Cited by 23
Raboisson, P., DesJarlais, R. L., Reed, R. L., Lattanze, J., Chaikin, M. A., Manthey, C. L., Tomczuk, B. E., & Marugán, J. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.10.015 · Cited by 22
Virtual High-Throughput Screening To Identify Novel Activin Antagonists
Zhu, J., Mishra, R. K., Schiltz, G. E., Makanji, Y., Scheidt, K. A., Mazar, A. P., & Woodruff, T. K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00753 · Cited by 21
In silico structure-based design and synthesis of novel anti-RSV compounds
Cancellieri, M., Bassetto, M., Widjaja, I., van Kuppeveld, F. J. M., de Haan, C. A. M., & Brancale, A. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.08.003 · Cited by 20
Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening
Cui, L., Lü, W., Lü, C., Xiao, W. J., Shen, X., Huang, J. Y., Liu, G., & Tang, Y. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-012-1394-3 · Cited by 20
Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors
Park, H., Kim, S., Kyung, A., Yoon, T., Ryu, S. E., & Jeong, D. G. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.083 · Cited by 20
Jang, J. W., Cho, N., Min, S., Cho, Y. S., Park, K. D., Seo, S. H., No, K. T., & Pae, A. N. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12654 · Cited by 20
Heusser, S. A., Howard, R. J., Borghese, C. M., Cullins, M. A., Broemstrup, T., Lee, U. S., Lindahl, E. R., Carlsson, J., & Harris, R. A. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087692 · Cited by 19
Petersen, G. O., Saxena, S., Renuka, J., Soni, V., Yogeeswari, P., Santos, D. S., Bizarro, C. V., & Sriram, D. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.05.001 · Cited by 19
A large scale virtual screen of DprE1
Wilsey, C., Gurka, J., Toth, D. M., & Franco, J. (2013) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2013.08.006 · Cited by 18
Lagos, C. F., Vecchiola, A., Allende, F. A., Fuentes, C., Tichauer, J. E., Valdivia, C. P., Solari, S., Campino, C., Tapia-Castillo, A., Baudrand, R. F., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.011 · Cited by 18
Virtual Ligand Screening Against Comparative Protein Structure Models
Fan, H., Irwin, J. J., & Šali, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-465-0_8 · Cited by 17
Self-citationShao, S., Yu, R., Yu, Y., & Li, Y. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2399-x · Cited by 17
Li, A., Sun, H., Du, L., Wu, X., Cao, J., You, Q., & Li, Y. (2014) · Journal of Molecular Modeling · doi:10.1007/s00894-014-2515-y · Cited by 16
In silico identification of novel ligands for G-quadruplex in the c-MYC promoter
Kang, H.-J., & Park, H. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9826-z · Cited by 16
Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation
He, J., Li, C., & Wu, G. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s74061 · Cited by 16
Stone, V. N., Parikh, H. I., Rami, F. E., Ge, X., Chen, W., Zhang, Y., Kellogg, G. E., & Xu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141126 · Cited by 16
Topomer CoMFA and Virtual Screening Studies of Azaindole Class Renin Inhibitors
Xiang, Y., Song, J., & Zhang, Z. (2014) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207317666140107094708 · Cited by 16
Cited by
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Self-citationComputational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
A practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546
“For instance, docking typically undersamples conformational states, ignores important terms (e.g., ligand strain) and approximates terms that it does include (e.g., fi xed potentials) 19,20 .”
BackgroundSelf-citationEfficient Exploration of Chemical Space with Docking and Deep Learning
Yang, Y., Yao, K., Repasky, M. P., Leswing, K., Abel, R., Shoichet, B. K., & Jerome, S. V. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00810 · Cited by 442
Self-citationSynthon-based ligand discovery in virtual libraries of over 11 billion compounds
Sadybekov, A. A., Sadybekov, A. V., Liu, Y., Iliopoulos-Tsoutsouvas, C., Huang, X.-P., Pickett, J., Houser, B., Patel, N., Tran, N. K., Tong, F., et al. (2022) · Nature · doi:10.1038/s41586-021-04220-9 · Cited by 417
“Standard libraries for high-throughput screening (HTS) 10 and virtual ligand screening (VLS) 11–13 have been historically limited to fewer than 10 million available compounds, which is a small fraction of the enormous chemical space, estimated to be 10 20 to 10 60 drug-like compounds 14,15 .”
Background
Metadata
- Authors
- Irwin, J. J., & Shoichet, B. K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-03-15
- Volume
- 59
- Issue
- 9
- Pages
- 4103-4120
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2274656763
- Cited by
- 277
- References
- 214
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.